Morten Svarer Hansen

Our lad from Portugal. Forever ❤️

You’ll Never Walk Alone ❤️

@moSth8 spoke to #BoneUp about the effect of semaglutide on bone mass - does weight loss lead to reduced bone strength? What can we do to prevent it? @richie_abel

Once-weekly semaglutide versus placebo in adults with increased fracture risk: a phase 2 RCT In adults with increased fracture risk, semaglutide once weekly did not increase bone formation based on bone formation marker P-PINP thelancet.com/journals/eclin… @moSth8 @frost_nielsen

@Atenisa1 Congrats. Well-deserved. :)

So thrilled my PhD thesis got accepted for a defence 👩🏻‍🔬 Such a great journey, loved everything about it ♥️🇩🇰

I am happy to share our latest paper! In this randomised clinical trial, we investigated the skeletal effects of the GLP-1 receptor agonist semaglutide in women and men with increased fracture risk but without diabetes. @frost_nielsen @EfeOuh sciencedirect.com/science/articl…

Remember to sign up for our PhD course on metabolic bone diseases. Great speakers and mentors, industry session, and project development in the beautiful town of Odense. Join us! @DDEA_Denmark @frost_nielsen

This open-access publication is the result of combining great international collaborations with fantastic supervisors and some osteoclast genetic dust from The Bioinformaticians magic wand: nature.com/articles/s4141… @frost_nielsen @RauchLabSDU @caroline_gorvin @KentSoee @KMEBLab

➡️Join us for the next ISBM ECI webinar: Bone and emerging incretin-based treatments for T2D and obesity with Prof. Morten Frost, JAN 25. 🦴🏋️ @frost_nielsen Register here: aarhusuniversity.zoom.us/meeting/regist…

Prof Alex Comninos from @ImperialMDR givingbhis outstanding teaching award lecture #bes2023 @Soc_Endo

ED Mills from @ImperialMDR giving the Early Career clinical prize lecture #bes2023 @Soc_Endo

@MohammadNasser @JBMRPlus Well done!

Our latest publication in @JBMRPlus reveals that fracture rates declined in Danish men with #T1D and #T2D, and in Danish women with #T2D. The decline may be attributable to improved #diabetes management. #epidemiology #fractures #diabetes doi.org/10.1002/jbm4.1…

@Peter_Aldiss @UoN_BDI @NottmBRCLiverGI Fantastic, Pete. Congrats! Hope the cortado does you well in Nottingham.

Amongst a mass of induction crap, grants, ethics and papers to write I completely forgot... I'm now a Junior Group Leader and Nottingham Research Fellow at @UoN_BDI & @NottmBRCLiverGI 🎉🎉

#tbt to two weeks ago when Dr. Joe Kodama won the Young Investigator award at #ASBMR2023!!

Congratulations to Rowan Hardy, @RowanSHardy1, who has been promoted to Associate Professor!! Well done Rowan!! 🎉🥳👏💪

Danish side Odense Boldklub have dropped the most metal football kit ever 😱

#PRESS Novo Nordisk product reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in trial

Congratulations to Dr @RowanSHardy1 who has received a UoB award for excellence in postdoctoral supervision. Rowan said, "Thank you to the past and present fantastic students who nominated me for the postdoctoral supervision award". Well done Rowan! #postdoc @UoBMDSPostGrad

@AniaJastreboff #ADA2023 presents the primary efficacy data for #weightloss for the Glucagon-GLP-1-GIP receptor tri-agonist for PPL with #obesity over 24-48 weeks. Starting BMI 37.3 @ADA_DiabetesPro @AmDiabetesAssn Up to 24% weight loss